|
|
|
|
Vol. 63, Issue 1, 111-118, January 2003
1A-Adrenoceptors and Improves Resistance against
Apoptosis in Coronary Endothelial Cells
Physiologisches Institut, Justus-Liebig-Universität, Giessen,
Germany
Parathyroid hormone-related peptide (PTHrP) is expressed throughout the
vascular system, including coronary endothelial cells. The regulation
of endothelial PTHrP expression and the role of PTHrP expression in
endothelial cells is not clear. This study investigates the question of
whether the stimulation of
-adrenergic or angiotensin II receptors
increases endothelial expression of PTHrP and whether endogenously
expressed PTHrP exerts intracrine effects in coronary endothelial
cells. We found that the stimulation of
1A-adrenoceptors, but not that of angiotensin II,
increases cellular expression of PTHrP in growing, but not in
growth-arrested, coronary endothelial cells. Angiotensin II increases
the expression of PTHrP in smooth muscle cells but not in endothelial
cells. PTHrP enters the nucleus of endothelial cells at the stadium of confluence, which suggests an intracrine effect of PTHrP. It was further investigated whether the down-regulation of endogenous PTHrP
expression by transfection with antisense oligonucleotides alters cell
proliferation or apoptosis resistance in growing or nongrowing
endothelial cells. Down-regulation of PTHrP did not modify cell
proliferation, but it increased the amount of UV-induced apoptosis. An
increased expression of PTHrP in cells pretreated with an
-adrenoceptor agonist reduced the basal rate of apoptosis and
improved resistance against UV-induced apoptosis. These results indicate a novel intracrine effect of PTHrP in coronary endothelial cells that improves cell survival. In endothelial cells, its
expression is regulated by
-adrenoceptor stimulation in a
cell-cycle-dependent and cell-type-specific manner.
This article has been cited by other articles:
![]() |
A. Halapas, P. Lembessis, I. Mourouzis, C. Pantos, D. V. Cokkinos, A. Sourla, and M. Koutsilieris Experimental hyperthyroidism increases expression of parathyroid hormone-related peptide and type-1 parathyroid hormone receptor in rat ventricular myocardium of the Langendorff ischaemia-reperfusion model Exp Physiol, February 1, 2008; 93(2): 237 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ross and K.-D. Schluter Cardiac-specific effects of parathyroid hormone-related peptide: Modification by aging and hypertension Cardiovasc Res, May 1, 2005; 66(2): 334 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Graupera, S. March, P. Engel, J. Rodes, J. Bosch, and J.-C. Garcia-Pagan Sinusoidal endothelial COX-1-derived prostanoids modulate the hepatic vascular tone of cirrhotic rat livers Am J Physiol Gastrointest Liver Physiol, April 1, 2005; 288(4): G763 - G770. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Maioli, V. Fortino, and A. Pacini Parathyroid Hormone-Related Protein in Preeclampsia: A Linkage Between Maternal and Fetal Failures Biol Reprod, December 1, 2004; 71(6): 1779 - 1784. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Grohe, M. van Eickels, S. Wenzel, R. Meyer, H. Degenhardt, P. A Doevendans, M. P Heinemann, G. Ross, and K.-D. Schluter Sex-specific differences in ventricular expression and function of parathyroid hormone-related peptide Cardiovasc Res, February 1, 2004; 61(2): 307 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Hastings, F. Araiza, D. W. Burton, L. Zhang, M. Bedley, and L. J. Deftos Parathyroid hormone-related protein ameliorates death receptor-mediated apoptosis in lung cancer cells Am J Physiol Cell Physiol, December 1, 2003; 285(6): C1429 - C1436. [Abstract] [Full Text] [PDF] |
||||